Recursion Provides Business Updates and Reports First Quarter 2022 Financial Results

/PRNewswire/ -- Recursion (Nasdaq: RXRX), the clinical-stage biotechnology company industrializing drug discovery by decoding biology, today reported business...

Related Keywords

Montreal ,Quebec ,Canada ,United States ,Salt Lake City ,Utah ,Toronto ,Ontario ,American ,Ryan Kelly ,Virgin Hyperloop ,Jared Allenbach ,Marie Evangelista ,Development Expenses ,American Association For Cancer Research ,Genentech ,Recursion Pharmaceuticals Inc ,Drug Administration ,Goldman Sachs ,Fast Track ,American Association ,Cancer Research ,Genentech Collaboration ,Administrative Expenses ,Shareholder Meeting ,Recursion Annual Meeting ,Vice President ,Senior Director ,Translational Medicine ,Frontier Medicines ,Chief Communications Officer ,Investor Relations ,Recursion Operating System ,Recursion Data ,Recursion Map ,San Francisco Bay ,Consolidated Statements ,Consolidated Balance Sheets ,Recursion ,